Sabrina serves as Director of Research and Development at T-CURX, bringing over nine years of pharmaceutical industry R&D expertise to T-CURX' leadership team and leveraging this R&D expertise for leading the internal CAR-T research and development efforts at T-CURX. Sabrina's career has centered on the development of innovative biological immunotherapeutics for cancer patients, with a proven track record of driving discovery from pre-IND stage towards clinical development.

At T-CURX, Sabrina spearheads discovery, pre-IND, and translational R&D activities. She is an experienced scientific leader, who previously held R&D leadership roles at MorphoSys in Munich and Bristol-Myers Squibb in the San Francisco Bay Area, U.S. As a trained cellular immunologist, Sabrina possesses a deep understanding of cellular immunotherapies, in particular myeloid cell biology, specifically myeloid-T cell cross-talk within the tumor microenvironment.